A detailed history of Holocene Advisors, LP transactions in Dexcom Inc stock. As of the latest transaction made, Holocene Advisors, LP holds 29,553 shares of DXCM stock, worth $2.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,553
Previous 1,773,235 98.33%
Holding current value
$2.22 Million
Previous $201 Million 99.02%
% of portfolio
0.01%
Previous 0.89%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $112 Million - $202 Million
-1,743,682 Reduced 98.33%
29,553 $1.98 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $15.1 Million - $19.3 Million
137,111 Added 8.38%
1,773,235 $201 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $4.2 Million - $5.15 Million
-36,790 Reduced 2.2%
1,636,124 $227 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $68.9 Million - $113 Million
-912,983 Reduced 35.31%
1,672,914 $208 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $84.5 Million - $135 Million
981,344 Added 61.16%
2,585,897 $241 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $10.5 Million - $12.2 Million
93,377 Added 6.18%
1,604,553 $206 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $12.8 Million - $15.1 Million
122,778 Added 8.84%
1,511,176 $176 Million
Q4 2022

Feb 14, 2023

SELL
$84.98 - $122.67 $29.2 Million - $42.2 Million
-343,669 Reduced 19.84%
1,388,398 $157 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $11.6 Million - $14.3 Million
-151,399 Reduced 8.04%
1,732,067 $140 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $99.1 Million - $194 Million
1,457,522 Added 342.19%
1,883,466 $140 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $19.5 Million - $26.9 Million
206,952 Added 94.5%
425,944 $218 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $4.13 Million - $5.17 Million
31,763 Added 16.96%
218,992 $118 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $15.2 Million - $20.4 Million
-142,718 Reduced 43.25%
187,229 $102 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $4.09 Million - $5.45 Million
-50,516 Reduced 13.28%
329,947 $141 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $15.9 Million - $19.6 Million
187,571 Added 97.24%
380,463 $137 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $12.4 Million - $16.7 Million
159,437 Added 476.57%
192,892 $71.3 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $1.44 Million - $1.7 Million
-15,077 Reduced 31.07%
33,455 $13.8 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $15.7 Million - $26.3 Million
-249,912 Reduced 83.74%
48,532 $19.7 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $8.12 Million - $12.8 Million
169,867 Added 132.11%
298,444 $80.4 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $4.53 Million - $7.09 Million
-123,729 Reduced 49.04%
128,577 $28.1 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $8.96 Million - $11.1 Million
252,306 New
252,306 $37.7 Million
Q2 2018

Aug 14, 2018

SELL
$17.54 - $25.22 $81,350 - $116,970
-4,638 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$13.06 - $18.54 $160,494 - $227,838
-12,289 Reduced 72.6%
4,638 $344,000
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $188,228 - $260,337
16,927
16,927 $971,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.